Medicare Enrolled

Dr. Kuppuswamy Jagarlamudi, M.D.

Hematology & Oncology · Mattoon, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1000 HEALTH CENTER DR, Mattoon, IL 61938
2172582250
In practice since 2008 (18 years)
NPI: 1194995357 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jagarlamudi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jagarlamudi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jagarlamudi

Dr. Kuppuswamy Jagarlamudi is a hematology & oncology specialist in Mattoon, IL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Jagarlamudi performed 1,217 Medicare services across 621 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jagarlamudi received a total of $15,732 from 63 pharmaceutical and/or device companies across 917 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jagarlamudi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 47% volume in IL $15,732 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,217
Medicare services
Top 47% in IL for hematology & oncology
621
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~68 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
740 $74 $473
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
344 $48 $298
New patient office visit, complex (60-74 min) 40 $144 $1,375
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
33 $49 $116
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
25 $113 $687
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
23 $106 $338
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $28 $118
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,732
Total received (2018-2024)
Avg $2,247/year across 7 years
Top 24% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
917
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,224 (77.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,508 (22.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,355
2023
$3,004
2022
$2,952
2021
$2,144
2020
$1,370
2019
$1,567
2018
$1,339

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$366
Novartis Pharmaceuticals Corporation
$347
Merck Sharp & Dohme LLC
$346
Astellas Pharma US Inc
$278
Lilly USA, LLC
$253
Janssen Biotech, Inc.
$218
AstraZeneca Pharmaceuticals LP
$203
ABBVIE INC.
$193
Daiichi Sankyo Inc.
$180
Celgene Corporation
$176
Incyte Corporation
$144
Gilead Sciences, Inc.
$71
Takeda Pharmaceuticals U.S.A., Inc.
$69
Eisai Inc.
$62
Genentech USA, Inc.
$60
E.R. Squibb & Sons, L.L.C.
$50
JAZZ PHARMACEUTICALS INC.
$43
Dendreon Pharmaceuticals LLC
$40
EMD Serono, Inc.
$35
Rigel Pharmaceuticals, Inc.
$31
Regeneron Healthcare Solutions, Inc.
$28
Karyopharm Therapeutics Inc.
$27
Stemline Therapeutics Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
Alexion Pharmaceuticals, Inc.
$21
Tempus AI, Inc
$20
SOBI, INC
$19
GlaxoSmithKline, LLC.
$15
ARRAY BIOPHARMA INC
$13
Top 3 companies account for 31.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,646
Janssen Biotech, Inc.
$1,522
AstraZeneca Pharmaceuticals LP
$983
Merck Sharp & Dohme LLC
$872
Lilly USA, LLC
$840
PFIZER INC.
$819
Astellas Pharma US Inc
$721
Incyte Corporation
$652
Celgene Corporation
$647
Seagen Inc.
$589
Genentech USA, Inc.
$575
Gilead Sciences, Inc.
$514
E.R. Squibb & Sons, L.L.C.
$514
ABBVIE INC.
$365
Merck Sharp & Dohme Corporation
$345
Eisai Inc.
$322
Pharmacyclics LLC, An AbbVie Company
$302
GENZYME CORPORATION
$266
Daiichi Sankyo Inc.
$263
Amgen Inc.
$246
EMD Serono, Inc.
$200
Bayer HealthCare Pharmaceuticals Inc.
$194
Janssen Pharmaceuticals, Inc
$180
Bayer Healthcare Pharmaceuticals Inc.
$155
Takeda Pharmaceuticals U.S.A., Inc.
$149
Karyopharm Therapeutics Inc.
$139
AbbVie Inc.
$131
Kite Pharma, Inc.
$105
SANOFI-AVENTIS U.S. LLC
$100
GlaxoSmithKline, LLC.
$100
AVEO Pharmaceuticals, Inc.
$98
Foundation Medicine, Inc.
$87
Rigel Pharmaceuticals, Inc.
$81
Janssen Products, LP
$80
Ipsen Biopharmaceuticals, Inc
$80
JAZZ PHARMACEUTICALS INC.
$75
EISAI INC.
$72
Taiho Oncology, Inc.
$61
ARRAY BIOPHARMA INC
$54
Dendreon Pharmaceuticals LLC
$53
Alexion Pharmaceuticals, Inc.
$50
Clovis Oncology, Inc.
$44
Regeneron Healthcare Solutions, Inc.
$41
MorphoSys, US Inc.
$38
Exelixis Inc.
$36
G1 Therapeutics, Inc.
$34
Jazz Pharmaceuticals Inc.
$25
Stemline Therapeutics Inc.
$23
Novocure Inc.
$22
Adaptive Biotechnologies Corporation
$21
Tempus AI, Inc
$20
Array BioPharma Inc.
$19
SOBI, INC
$19
Heron Therapeutics, Inc.
$18
ADC Therapeutics America, Inc.
$18
Epizyme, Inc.,
$18
TG Therapeutics, Inc.
$18
CTI BioPharma Corp.
$16
Pharmacyclics LLC, an AbbVie Company
$12
Coherus Biosciences Inc.
$11
MEDIVATION FIELD SOLUTIONS LLC
$11
Sysmex Inostics Inc
$11
Tactile Systems Technology Inc
$11
Top 3 companies account for 26.4% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · Abraxane · Alecensa · Avastin · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · Bavencio · Braftovi · CALQUENCE · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DAURISMO · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Erleada · FASLODEX · FLEXITOUCH · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · Hemlibra · IBRANCE · IMBRUVICA · IMFINZI · IMLYGIC · INJECTAFER · INLYTA · INQOVI · INREBIC · IRESSA · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MYLOTARG · Neulasta · Nplate · Nubeqa · ONUREG · OPDIVO · OPDUALAG · Oncology · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VOTRIENT · VYNDAQEL · Vectibix · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Mattoon?
Compare hematology & oncology specialists in the Mattoon area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
5
Per 100K population
10.7
County median income
$56,040
Nearest hospital
SARAH BUSH LINCOLN HEALTH CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Jagarlamudi is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Jagarlamudi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Jagarlamudi performed 740 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jagarlamudi receive payments from pharmaceutical companies?
Yes. Dr. Jagarlamudi received a total of $15,732 from 63 companies across 917 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jagarlamudi's costs compare to other hematology & oncology specialists in Mattoon?
Dr. Jagarlamudi's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jagarlamudi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →